Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Quality indicators for sentinel lymph node biopsy: is there room for improvement?

Acuna SA, Angarita FA, McCready DR, Escallon J.

Can J Surg. 2013 Apr;56(2):82-8. doi: 10.1503/cjs.033011.

2.

Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.

Intra M, Trifirò G, Viale G, Rotmensz N, Gentilini OD, Soteldo J, Galimberti V, Veronesi P, Luini A, Paganelli G, Veronesi U.

Ann Surg Oncol. 2005 Nov;12(11):895-9. Epub 2005 Sep 29.

PMID:
16195833
3.

Measuring the quality of sentinel lymph node biopsy (SLNB) for breast cancer: a population-based evaluation.

Wells B, Saskin R, Wright F, McCready D, Quan ML.

Ann Surg Oncol. 2013 Feb;20(2):615-9. doi: 10.1245/s10434-012-2626-6. Epub 2012 Sep 1.

PMID:
22941174
4.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
5.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
6.

Sentinel lymph node biopsy for localised ductal carcinoma in situ?

Veronesi P, Intra M, Vento AR, Naninato P, Caldarella P, Paganelli G, Viale G.

Breast. 2005 Dec;14(6):520-2. Epub 2005 Sep 26.

PMID:
16185871
7.

Quality indicators for ductal carcinoma in situ (DCIS) of the breast: development using a multidisciplinary delphi process and its use in monitoring population-based treatment.

Chin-Lenn L, Craighead P, Bryant HE, Mack L, Temple W, Ghali W, Quan ML.

J Surg Oncol. 2013 Nov;108(6):348-51. doi: 10.1002/jso.23401. Epub 2013 Aug 22.

PMID:
24038038
8.

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.

Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.

J Surg Oncol. 2003 Oct;84(2):63-7.

PMID:
14502778
9.

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.

Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD.

Curr Surg. 2005 Mar-Apr;62(2):253-7.

PMID:
15796952
10.

Beyond the false negative rate: development of quality indicators for sentinel lymph node biopsy in breast cancer.

Quan ML, Wells BJ, McCready D, Wright FC, Fraser N, Gagliardi AR.

Ann Surg Oncol. 2010 Feb;17(2):579-91. doi: 10.1245/s10434-009-0658-3. Epub 2009 Aug 26.

PMID:
19707833
11.

Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.

Camp R, Feezor R, Kasraeian A, Cendan J, Schell S, Wilkinson E, Copeland E, Lind S.

Breast J. 2005 Nov-Dec;11(6):394-7.

PMID:
16297082
12.

Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy.

Civantos FJ, Moffat FL, Goodwin WJ.

Laryngoscope. 2006 Mar;112(3 Pt 2 Suppl 109):1-15.

PMID:
16540925
13.

Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.

Yen RF, Kuo WH, Lien HC, Chen TH, Jan IS, Wu YW, Wang MY, Chang KJ, Huang CS.

J Formos Med Assoc. 2007 Jan;106(1):44-50.

14.

A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.

Kootstra JJ, Hoekstra-Weebers JE, Rietman JS, de Vries J, Baas PC, Geertzen JH, Hoekstra HJ.

Ann Surg Oncol. 2010 Sep;17(9):2384-94. doi: 10.1245/s10434-010-0981-8. Epub 2010 Mar 11.

15.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
16.

The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology.

Luini A, Galimberti V, Gatti G, Arnone P, Vento AR, Trifirò G, Viale G, Rotmensz N, Fernandez JR, Gilardi D, Paganelli G.

Breast Cancer Res Treat. 2005 Jan;89(2):159-63.

PMID:
15692758
17.

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.

J Clin Oncol. 2009 Jun 20;27(18):2946-53. doi: 10.1200/JCO.2008.19.5750. Epub 2009 Apr 13.

18.

Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.

Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L.

Eur J Surg Oncol. 2003 Apr;29(3):221-3.

PMID:
12657230
19.
20.

[Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].

Huang XY, Wu J, Liu ZB, Zhang JX, Han QX, Xu WP, Ping B, Yang WT, Shen ZZ, Shao ZM.

Ai Zheng. 2007 Oct;26(10):1133-7. Chinese.

PMID:
17927887
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk